# An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections

> **NCT01823289** · PHASE4 · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 71 (actual)

## Conditions studied

- Pulmonary Fungal Infection

## Interventions

- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT01823289
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2013-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823289, "An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01823289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*